Wardwizard Healthcare Limited (BOM:512063)
India · Delayed Price · Currency is INR 45.34
+2.15 (4.98%)
At close: Dec 22, 2025
Wardwizard Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 13.04 | 8.44 | 4.17 | 1.11 | 1.35 | 1.64 |
Other Revenue | 4.15 | 4.24 | - | 0.04 | 0 | - |
| 17.19 | 12.68 | 4.17 | 1.15 | 1.35 | 1.64 | |
Revenue Growth | 63.48% | 204.08% | 263.87% | -15.17% | -17.57% | -26.91% |
Cost of Revenue | 10.95 | 6.46 | 10.39 | 1.94 | 1 | 1.11 |
Gross Profit | 6.23 | 6.22 | -6.22 | -0.8 | 0.35 | 0.53 |
Selling, General & Admin | - | 2.01 | 0.33 | 0.24 | - | - |
Other Operating Expenses | 9.68 | 6.16 | 11.25 | 2.07 | 0.65 | 0.61 |
Operating Expenses | 11.08 | 9.94 | 16.54 | 3.12 | 0.65 | 0.61 |
Operating Income | -4.85 | -3.72 | -22.75 | -3.91 | -0.3 | -0.07 |
Interest Expense | -0.14 | -0.75 | -5.51 | -0.26 | - | - |
Interest & Investment Income | - | - | - | - | 0.01 | 0.01 |
Other Non Operating Income (Expenses) | 0 | - | - | - | - | -0 |
EBT Excluding Unusual Items | -4.99 | -4.47 | -28.27 | -4.17 | -0.29 | -0.06 |
Gain (Loss) on Sale of Investments | - | -2.07 | - | - | - | - |
Other Unusual Items | - | 4.29 | 0.02 | - | - | - |
Pretax Income | -4.99 | -2.25 | -28.25 | -4.17 | -0.29 | -0.06 |
Income Tax Expense | -0.71 | 0.9 | -1.12 | 0.32 | 0.02 | - |
Net Income | -4.28 | -3.15 | -27.13 | -4.49 | -0.31 | -0.06 |
Net Income to Common | -4.28 | -3.15 | -27.13 | -4.49 | -0.31 | -0.06 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change | 1.80% | - | - | - | - | - |
EPS (Basic) | -17.15 | -12.87 | -110.75 | -18.31 | -1.27 | -0.25 |
EPS (Diluted) | -17.15 | -12.87 | -110.75 | -18.31 | -1.27 | -0.25 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1.91 | -16.42 | -3.66 | -0.1 | -0.46 |
Free Cash Flow Per Share | - | -7.80 | -67.04 | -14.94 | -0.42 | -1.86 |
Gross Margin | 36.26% | 49.05% | -149.06% | -69.55% | 25.76% | 32.58% |
Operating Margin | -28.24% | -29.31% | -545.59% | -341.36% | -22.35% | -4.39% |
Profit Margin | -24.89% | -24.87% | -650.67% | -391.45% | -22.95% | -3.72% |
Free Cash Flow Margin | - | -15.07% | -393.86% | -319.46% | -7.70% | -27.82% |
EBITDA | -2.65 | -3.57 | -22.73 | -3.11 | - | - |
EBITDA Margin | -15.42% | -28.17% | - | -270.94% | - | - |
D&A For EBITDA | 2.2 | 0.14 | 0.02 | 0.81 | - | - |
EBIT | -4.85 | -3.72 | -22.75 | -3.91 | -0.3 | -0.07 |
EBIT Margin | -28.24% | -29.31% | - | - | -22.35% | -4.39% |
Revenue as Reported | 17.19 | 16.97 | 4.19 | 1.15 | 1.37 | 1.65 |
Advertising Expenses | - | 0.16 | 0.21 | 0.16 | - | - |